Annual Report And Accounts

Overview

The report describes Oxford Biomedica's 2022 expansion into the US and AAV manufacturing through the Oxford Biomedica Solutions acquisition, alongside continued growth in its viral-vector CDMO business. It reports 904 year-end employees and a material ESG programme covering people, community, innovation, supply chain and environmental performance. The Group reports 4,475 tCO2e of location-based emissions, 2,935 tCO2e on a market basis and total energy usage of 14,049,362 kWh. It also sets out TCFD-aligned climate disclosures and a commitment to achieve net zero GHG emissions across all operations by 2040.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022
Period: Ends 31 December 2022
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services